Site Members can sign up for company wide alerts
Investigation Overview
After the Valeant Pharmaceuticals board of directors announced the proposal by Biovail to merge with Valeant Pharmaceuticals Intl. several investigations on behalf of current investors Valeant Pharmaceuticals International (NYSE:VRX) over possible breaches of fiduciary duty by the board of directors of Valeant Pharmaceuticals was announced. The investigation by a law firm focuses on p...
You must register (for free) or login to view the entire investigation.